pharma · Advanced Solid Tumors · Solid Tumor · PYXS
Pyxis Oncology
Pyxis Oncology is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker PYXS. Primary therapeutic focus areas include Advanced Solid Tumors, Solid Tumor, Solid Tumors, Advanced solid tumors,
Boston, USA HQ
2019 Founded
71 Employees
Public company Type
PYXS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2019
- Employees
- 71
- Programs
- 8
- Drugs
- 6
- Patents
- 3
APX005M
Phase 2 · small molecule · Melanoma
APX005M for Melanoma is a Phase 2 program (small_molecule) at Pyxis Oncology with 1 ClinicalTrials.gov record(s).
Internal code 2015-0654
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Pyxis Oncology
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Melanoma
- Status
- terminated
- Trials
- 1